Versant-backed Jecure launches to tackle NASH

Wednesday, February 15, 2017 - 08:21 in Mathematics & Economics

Biotech will use $20 million in funding to develop first-in class compounds

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net